Hidden Crisis in Maternal Health: WHO to Tackle Rising Tide of Chronic Conditions in Pregnancy

GENEVA — In a major shift for global maternal health strategy, the World Health Organization (WHO) has announced an emergency mobilization to establish the first-ever global care guidelines for pregnant and postpartum women living with chronic, non-communicable diseases (NCDs). Driven by a shifting tide in maternal mortality where underlying conditions like diabetes, high blood pressure, and heart disease have become top killers of expectant mothers, the WHO has scheduled an urgent expert convening for June 30, 2026. The virtual assembly aims to transform complex clinical science into practical, localized tools capable of saving lives across radically different healthcare systems, particularly in regions where specialist care is nearly non-existent.

A Shift in How Mothers Are Dying

For decades, global maternal health initiatives focused almost exclusively on direct obstetric emergencies: catastrophic bleeding, obstructed labor, and severe infections. While these remain critical threats, epidemiologists are tracking an alarming evolution in the data.

According to the most recent data from the WHO and a landmark study published in The Lancet Global Health, indirect causes linked to NCDs now account for roughly 23% of maternal deaths worldwide. This makes chronic illnesses the second leading cause of maternal mortality globally, surpassed only by postpartum hemorrhage. With approximately 287,000 women dying from pregnancy-related complications annually—amounting to roughly 800 preventable deaths every single day—health authorities warn that ignoring pre-existing chronic diseases makes it impossible to achieve global maternal survival targets.

The Compounding Risks for Mother and Child

Living with a chronic condition during pregnancy creates a dangerous physiological feedback loop, triggering severe short-term complications and anchoring lifetime health risks for both mother and child.

In the immediate term, NCDs dramatically spike the rate of dangerous pregnancy anomalies. For instance, maternal obesity and pre-existing hypertension nearly double the risk of developing gestational diabetes.

Beyond the immediate delivery window, the long-term prognosis for these families is reshaping cardiovascular medicine. A massive meta-analysis spanning 3.5 million women demonstrated that individuals with a history of pre-eclampsia face a profound lifetime risk of experiencing a stroke, ischemic heart disease, and venous thromboembolism (blood clots).

“We used to view conditions like pre-eclampsia or gestational diabetes as temporary complications that resolved the moment the placenta was delivered,” explains Dr. Aris Papageorghiou, a professor of fetal medicine who is not involved in the current WHO guidelines development. “We now know these conditions act as a natural stress test, unmasking an underlying predisposition to cardiovascular disease. Women who navigate these complications often experience their first major cardiovascular event by a mean age of just 38 years.”

Furthermore, the threat crosses the placental barrier. Children born to mothers with poorly managed NCDs face altered metabolic programming in utero, making them significantly more vulnerable to developing childhood obesity, early-onset diabetes, and cardiovascular complications later in life.

Cardiovascular Disease: The Silent Frontrunner

While metabolic disorders present a steep hill to climb, cardiovascular disease (CVD) has quietly emerged as the single most severe threat within the NCD spectrum for pregnant patients. Medical data shows that cardiovascular diseases are present in 1% to 4% of all pregnancies, a number steadily climbing as the average maternal age rises and baseline metabolic health markers decline globally.

According to clinical reviews published via PubMed Central, the risk multiplier for an expectant mother with an underlying cardiac condition is staggeringly high:

Any patient entering pregnancy with a pre-existing, underlying cardiovascular disease faces an 18-fold greater odds of experiencing an adverse cardiac outcome compared to a healthy patient.

For women diagnosed with specific conditions like cardiomyopathy (chronic disease of the heart muscle), that risk skyrockets to nearly 50-fold greater odds of experiencing a major adverse cardiac event during gestation or the postpartum period. Experts stress that managing these patients safely requires an extensive multidisciplinary team involving cardiologists, maternal-fetal medicine specialists, and specialized obstetricians—a luxury many communities simply cannot afford.

Bridging the Gap: The Guidelines and the Reality

The groundwork for this global initiative began in 2025 when the WHO released its first clinical guidelines targeting specific high-risk conditions during pregnancy, notably sickle cell anemia and diabetes. The 2025 sickle cell guidelines delivered more than 20 rigorous recommendations, detailing strict regimens for folic acid and iron supplementation, acute pain crisis management, infection prevention, prophylactic blood transfusions, and intensive fetal monitoring.

However, moving these intricate guidelines from paper to the clinic has exposed massive logistical divides. In low- and middle-income countries (LMICs), severe shortages of specialists mean that general midwives and rural community health workers are left to navigate highly technical protocols alone.

Furthermore, the issue isn’t exclusive to developing regions. Even in high-income nations, maternal health infrastructure is frequently siloed. Expectant mothers are routed through routine prenatal tracks where complex NCD monitoring is routinely overlooked or completely separated from primary medical care. Because prenatal visits are often a woman’s first sustained interaction with a healthcare system, missing the window to screen for and manage chronic disease represents a catastrophic lost opportunity.

The upcoming virtual convening on June 30, 2026, is specifically designed to bridge this implementation gap. The invited panel of experts will focus on crafting “derivative tools”—highly simplified, adaptable clinical charts and digital toolkits—that enable frontline nurses and midwives to screen, track, and stabilize chronic conditions without needing immediate access to a major research hospital.

Limitations and Transparency Concerns

Despite the optimism surrounding the initiative, public health observers urge a realistic assessment of the strategy’s limitations. The June 30 expert convening is strictly an invitation-only closed session, which has drawn some scrutiny regarding equity in representation.

To maintain strict scientific integrity, the WHO operates under an open transparency policy, putting the biographies of all participating experts online and actively inviting public feedback regarding any potential conflicts of interest. The WHO notes that these experts participate entirely in their individual capacities, and their presence does not imply official WHO endorsement of their past research.

Furthermore, critics point out that guidelines alone cannot repair broken health infrastructure. A clinical manual cannot manufacture insulin, provide blood pressure monitors, or solve the severe shortage of medical professionals in rural areas. Without deep financial investment from global governments to support structural integration, the clinical recommendations risk becoming unachievable gold standards.

Action Plan for Patients and Providers

As the global medical landscape shifts, health professionals and health-conscious consumers must adapt their approach to pregnancy planning.

For Expectant and Planning Mothers:

• Schedule Pre-Conception and Early Screenings: If you have a history of diabetes, high blood pressure, asthma, kidney issues, or mental health disorders, discuss them with your care provider before conceiving or during your very first prenatal appointment.

• Advocate for Comprehensive Care: Do not assume your prenatal check-ups automatically cover chronic disease management. Explicitly ask how your underlying health conditions will be integrated into your birthing plan.

• Prioritize the Postpartum Window: Do not stop tracking your health after birth. If you experienced pre-eclampsia or gestational diabetes, establish a long-term cardiovascular health tracking plan with a primary care doctor, as these conditions are now recognized markers for premature heart disease.

For Healthcare Professionals:

• Break Down Clinical Silos: Obstetricians and midwives must actively coordinate care with endocrinologists, cardiologists, and mental health professionals.

• Utilize Frontline Screening Opportunities: Treat every routine prenatal visit as a critical window to monitor baseline metabolic and cardiovascular health markers.

The path forward hinges on complete integration. Public health advocates argue that embedding chronic disease screening and care directly into existing reproductive and maternal health services is the most cost-effective, sustainable, and equitable strategy available. In an era where chronic illness dominates global health patterns, separating maternal care from NCD management is no longer a viable option—it is a dangerous gap that the global health community must close.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• https://www.who.int/news/item/15-06-2026-caring-for-non-communicable-diseases-during-pregnancy–expert-convening